Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice
Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice have?
Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice has 58 citations in the OpenAlex counts ScholarIQ stores.
When was Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice published?
Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice has 2005 year in the ScholarIQ index.
What is the open-access status of Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice?
Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice has closed oa status in the ScholarIQ index.
What is the DOI of Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice?
The DOI for Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice is on the source record.
What is the PMID of Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice?
The PMID for Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice is on the source record.
What is the OpenAlex record for Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice?
The OpenAlex for Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice is on the source record.